-
A Chance for Kids & Families
A Chance for Kids & Families raised $462,102 in 2025 for cancer research and patient care at Dana-Farber Cancer Institute. Throughout the summer, patrons who donated to the Jimmy Fund at participating Burger King®, The Paper Store®, Uncharted, and Valvoline Instant Oil ChangeSM locations received a coupon, with all proceeds supporting Dana-Farber’s lifesaving mission.
-
Cure Childhood Cancer
Dana-Farber Cancer Institute’s Emily Heikamp, MD, PhD, MSc, received a $220,000 Early Investigator Award from CURE Childhood Cancer. This generous grant supports her research focused on determining whether targeting two proteins can effectively treat a specific type of acute myeloid leukemia. The grant also helps launch her career as an independent investigator.
-
Matthew Larson Foundation for Pediatric Brain Tumors
The Matthew Larson Foundation for Pediatric Brain Tumors awarded $450,000 to Pratiti (Mimi) Bandopadhayay, MBBS, PhD, to advance research aimed at overcoming therapeutic resistance in pediatric brain tumors. Such pivotal support empowers her team to accelerate discoveries with the potential to deliver more effective treatments for young patients, honoring Matt’s legacy and inspiring hope.
-
The Impact You Have Made Possible
Each year, Dana-Farber Cancer Institute aspires to provide the care and treatment our patients deserve. We are able to achieve these ambitions because of our dedicated donor community.
-
Jimmy Fund Radio-Telethon breaks records with $5.7 million raised for Dana-Farber
The WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance continued to be a beacon of support for Dana-Farber Cancer Institute and the Jimmy Fund in August with a record-breaking fundraising year.
-
Teen Cancer America Partnership anniversary honored by rock legend Sir Roger Daltrey
Legendary rock icon Sir Roger Daltrey, lead singer of The Who and co-founder of Teen Cancer America (TCA), visited Dana-Farber Cancer Institute on Aug. 26 to mark the 10th anniversary of Dana-Farber’s partnership with TCA.
-
The Dana-Farber Society
The Dana-Farber Society (DFS) is a group of visionary donors who are changing lives and creating a legacy through a planned gift such as a bequest, life income gift, or beneficiary designation to Dana-Farber Cancer Institute, the Jimmy Fund, the Friends of Dana-Farber, or the Pan-Mass Challenge.
-
Children’s Cancer Research Fund
The Children’s Cancer Research Fund made two grants totaling $350,000 to support an early phase trial for relapsed pediatric liver cancer led by Allison O’Neill, MD, and liquid biopsy research in rhabdomyosarcoma led by Brian Crompton, MD. These pivotal resources help to develop more effective precision therapies for children facing aggressive cancers.
-
Charles H. Hood Foundation
The Charles H. Hood Foundation awarded Emily Heikamp, MD, PhD, MSc, a generous $200,000 grant to study a combination treatment for acute myeloid leukemia targeting oncogenic fusion proteins and foster her career development as an independent investigator. This funding supports high-risk, high-reward pediatric studies, enabling groundbreaking discoveries, improved care, and ideally better outcomes for young…
-
Anne Marie & Salvatore Torregrossa
Anne Marie and Salvatore Torregrossa made a generous $100,000 gift to support pediatric cancer research and care led by Lisa Diller, MD, at Dana-Farber Cancer Institute. Their contribution will help advance groundbreaking discoveries and improve care for children facing cancer, continuing Torregrossa’s legacy of compassion and commitment to our lifesaving mission.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.